Destiny Pharma PLC - ESG Rating & Company Profile powered by AI
If you are employed by Destiny Pharma PLC and you wish to licence your ESG rating, please get in touch. This ESG score for Destiny Pharma PLC indicates the company's transparency towards the United Nations Sustainable Development Goals. This assessment of Destiny Pharma PLC was assembled by All Street Sevva using leading artificial intelligence.
Destiny Pharma PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 6.0, social score of 4.0 and governance score of 5.7.
5.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 912 | Vivanza Biosciences Ltd | 5.3 | High |
| 912 | ValiRx PLC | 5.3 | High |
| 958 | Destiny Pharma PLC | 5.2 | High |
| 958 | Altimmune Inc | 5.2 | High |
| 958 | Agios Pharmaceuticals Inc | 5.2 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Destiny Pharma PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Destiny Pharma PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Destiny Pharma PLC report the average age of the workforce?
Sign up for free to unlockDoes Destiny Pharma PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Destiny Pharma PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Destiny Pharma PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Destiny Pharma PLC offer flexible work?
Sign up for free to unlockDoes Destiny Pharma PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Destiny Pharma PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Destiny Pharma PLC conduct supply chain audits?
Sign up for free to unlockDoes Destiny Pharma PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Destiny Pharma PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Destiny Pharma PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Destiny Pharma PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Destiny Pharma PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Destiny Pharma PLC disclose water use targets?
Sign up for free to unlockDoes Destiny Pharma PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Destiny Pharma PLC have a product recall in the last two years?
Sign up for free to unlockDoes Destiny Pharma PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Destiny Pharma PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Destiny Pharma PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Destiny Pharma PLC disclose parental leave metrics?
Sign up for free to unlockDoes Destiny Pharma PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Destiny Pharma PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Destiny Pharma PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Destiny Pharma PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Destiny Pharma PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Destiny Pharma PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Destiny Pharma PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Destiny Pharma PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Destiny Pharma PLC disclose its waste policy?
Sign up for free to unlockDoes Destiny Pharma PLC report according to TCFD requirements?
Sign up for free to unlockDoes Destiny Pharma PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Destiny Pharma PLC disclose energy use targets?
Sign up for free to unlockDoes Destiny Pharma PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Destiny Pharma PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Destiny Pharma PLC
These potential risks are based on the size, segment and geographies of the company.
Destiny Pharma plc, a biotechnology company, focuses on the discovery, development, and commercialization of medicines for the treatment of infectious diseases in the United Kingdom. The company is involved in developing NTCD-M3 that is in Phase III clinical trial for the prevention of recurrent Clostridioides diffcile infections; XF-73 Nasal, which is in Phase II clinical trial for the prevention of post-surgical staphylococcal infection; and XF-73 Dermal that is in Phase I clinical trial for the treatment of skin infections of antibiotic resistant bacteria. It also develops SPOR-COV, biotherapeutic product, which is in preclinical stage for the prevention of COVID-19 and other viral respiratory infections; and XF Drugs Biofilm that is in preclinical stage for the treatment of antibiotic resistant biofilm and bacterial aggregate associated infections. In addition, the company is involved in the development of XF drugs for the treatment of respiratory, oral mucosa, and ocular infection diseases. Destiny Pharma plc has collaboration agreements with China Medical System Holdings Limited; SporeGen Limited; the University of Southampton; Aston University; the University of Sheffield; and Cardiff University and Tianjin Medical University. The company was incorporated in 1996 and is based in Brighton, the United Kingdom.